Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
This study has been completed.
Study NCT00562380 Information provided by National Cancer Institute (NCI)
First Received on November 21, 2007. Last Updated on June 29, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Prostate Cancer
Sarcoma
Small Intestine Cancer
Additional conditions recognized in this trial
Duodenal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Lymphoma, Non-Hodgkin
Neoplasms
Prostatic Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Ileal Diseases
Immune System Diseases
Immunoproliferative Disorders
Intestinal Diseases
Jejunal Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
ganitumab
laboratory biomarker analysis
pharmacological study
biopsy
Sponsors listed in this trial
Amgen
National Cancer Institute (NCI)
Back to top of Main Content
